Yet Another Study Determines Psilocybin Provides 'Rapid and Sustained Anti-Depressant Effect'

New Study Determines Psilocybin Provides ‘Rapid and Sustained Antidepressant Effect’

,
One of the largest studies yet lends more evidence to the view that psilocybin "may hold promise as a novel intervention for major depressive disorder."
30 Days, 30 Psychedelic Retreats - Lessons Learned From Our Quest to Study Central American Retreats and Their Potential to Heal Minds

30 Days, 30 Psychedelic Retreats – Lessons Learned From Our Quest to Study Central American Retreats and Their Potential to Heal Minds

,
My journey through 30 retreats made it quite clear that every center has a somewhat unique philosophy of care. With much of the science still early and murky, it’s difficult to say that one approach is better or worse than any others.
Psychedelic-Therapy As Employee Health Benefit is Becoming Possible and the First Results Are In

Psychedelic Therapy As Employee Health Benefit Is Becoming Possible and the First Results Are In

No fewer than 50 companies have shown interest in offering psychedelic therapy to their employees through healthcare plan startup Enthea.

First-Ever Professional Guidelines for Psychedelic-Assisted Therapy Practitioners Now Published by APPA and BrainFutures

The first-ever set of professional practice guidelines for psychedelic-assisted therapy were officially published today.

Is the Trip Enough? Why Psychedelic Integration Therapy Is Important to Maximize the Benefits of Your Trip

,
Psychedelic integration therapy is a powerful, essential tool that can maximize the therapeutic benefits of psychedelic experiences.
Kanna-This Legal Psychoactive Holds Promise for Stress, Anxiety and Beyond

Kanna-This Legal Psychoactive Holds Promise for Stress, Anxiety and Beyond

,
Kanna has gained popularity in recent years as a legal and non-psychedelic alternative to traditional psychedelics for anxiety and stress relief.
Australia Becomes the First Country to Prescribe Psychedelics to Treat Depression and PTSD

Australia Becomes the First Country to Prescribe Psychedelics to Treat Depression and PTSD

,
Australia has become the first country to prescribe MDMA to treat PTSD and psilocybin to combat treatment-resistant depression.
Inside Ibogaine: The Overlooked Yet Promising Psychedelic for Addiction Recovery

Inside Ibogaine: The Overlooked Yet Promising Psychedelic for Addiction Recovery

,
Ibogaine’s anti-addictive properties are known to work wonders on people struggling with various substances, such as cocaine, amphetamines, alcohol, nicotine and more.
The Biggest Psychedelic News Stories of the Week – June 23

The Biggest Psychedelic News Stories of the Week – June 23

,
New study brings hope to cancer patients struggling with depressive symptoms. Conflicts in Kentucky commission developing plan to fund research on the benefits of ibogaine to treat opioid addiction. Ayahuasca played a key role in finding Colombian children stranded in the Amazonian jungle.
Will the UK’s Ambitious Life Sciences Investment Power-Up the Psychedelic Sector?

Will the UK’s Ambitious Life Sciences Investment Power-Up the Psychedelic Sector?

,
As an emerging innovative sector addressing unmet mental health needs, psychedelic drug developers are poised to greatly benefit from the diverse initiatives offered within this package.